Mereo BioPharma Group plc (LON:0A9G)
London · Delayed Price · Currency is GBP · Price in USD 0.3929
-0.0188 (-4.56%)
At close: Feb 11, 2026
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of 45.41 million as of February 12, 2026. Its market cap has decreased by -87.30% in one year.
Market Cap
45.41M
Enterprise Value
9.95M
Revenue
371.97K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from 96.41M to 45.41M, a decrease of -52.90%. That is a compound annual growth rate of -10.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 46.08M | -6.47% |
| Dec 31, 2025 | 49.27M | -88.62% |
| Dec 31, 2024 | 433.05M | 70.57% |
| Dec 29, 2023 | 253.89M | 249.41% |
| Dec 30, 2022 | 72.66M | -43.40% |
| Dec 31, 2021 | 128.39M | -27.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Schroder BSC Social Impact Trust | 50.59M |
| Life Settlement Assets | 50.55M |
| BATM Advanced Communications | 49.14M |
| Time Finance | 49.05M |
| RM Infrastructure Income | 47.60M |
| Octopus Future Generations VCT | 47.49M |
| LendInvest | 45.34M |
| Palace Capital | 43.48M |